Neurology Central

Astrocytes identified as potential therapeutic target for the treatment of Huntington’s disease


Researchers from University of California Los Angeles (CA, USA) have identified that astrocytes affected by the huntingtin gene mutation are linked to the neuropsychiatric symptoms associated with Huntington’s disease. The results of the study, published in Science Translational Medicine, presents astrocytes as a potential therapeutic target for the neurological disorder.  

This is the first study to identify how the huntingtin mutation affects astrocytes. While it is well known that the mutation leads to neuronal cell death, little is known about the impact of astrocyte activity in the progression of Huntington’s disease. 

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.